CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 101 filers reported holding CUE BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $48,295 | +110.0% | 13,528 | +29.6% | 0.00% | +100.0% |
| Q3 2022 | $23,000 | -28.1% | 10,441 | -6.6% | 0.00% | 0.0% |
| Q2 2022 | $32,000 | -28.9% | 11,175 | +16.0% | 0.00% | 0.0% |
| Q1 2022 | $45,000 | -58.7% | 9,634 | +0.3% | 0.00% | -50.0% |
| Q4 2021 | $109,000 | -29.7% | 9,602 | -12.1% | 0.00% | -33.3% |
| Q3 2021 | $155,000 | +38.4% | 10,922 | +17.8% | 0.00% | +50.0% |
| Q2 2021 | $112,000 | +4.7% | 9,268 | -0.1% | 0.00% | 0.0% |
| Q1 2021 | $107,000 | -43.7% | 9,275 | -37.0% | 0.00% | -50.0% |
| Q4 2020 | $190,000 | -25.5% | 14,727 | -10.9% | 0.00% | -50.0% |
| Q3 2020 | $255,000 | +34.9% | 16,531 | +104.5% | 0.01% | +14.3% |
| Q2 2020 | $189,000 | – | 8,085 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 890,000 | $7,503,000 | 0.50% |
| Nantahala Capital Management | 1,378,198 | $11,618,000 | 0.43% |
| 683 Capital Management, LLC | 300,000 | $2,529,000 | 0.28% |
| Rock Creek Group, LP | 42,505 | $358,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $422,000 | 0.06% |
| Parian Global Management LP | 11,000 | $93,000 | 0.04% |
| Sigma Planning Corp | 60,210 | $508,000 | 0.02% |
| D'Orazio & Associates, Inc. | 2,000 | $17,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 26,602 | $224,000 | 0.01% |
| STIFEL FINANCIAL CORP | 55,855 | $471,000 | 0.00% |